Loading...

Michelle A Albert, MD, MPH

TitleProfessor
SchoolUCSF School of Medicine
DepartmentMedicine
vCardDownload vCard

    Collapse Biography 
    Collapse Awards and Honors
    American Heart Association2018Merit Award
    American Heart Association2016Women in Cardiology Mentoring Award
    Association of University Cardiologists2016Elected Member
    Haverford College2015The Haverford Award, recognizing an alumnus who uses their knowledge to the benefit of society
    Circulation Journal (June 17, 2014)2014Featured "Editor's Choice & Scientist": MA Health Care Reform, Race/Ethnicity and CVD
    Women's Day Magazine2014Red Dress Award Honoree
    American College of Cardiology2012Second Annual Heart of Women's Health CREDO Award
    Brigham and Women’s Hospital, Boston MA2010Nesson Fellowship Award
    Brigham and Women's Hospital, Boston MA2006J Ira and Nikki Harris Family Research Award
    Brigham and Women’s Hospital, Boston MA2003Learner Young Investigator Award,
    Association of Black Cardiologists, Inc2004Herbert W. Nickens Epidemiology Award
    Brigham and Women’s Hospital, Boston MA2001Brigham and Women's Hospital/Kraft Minority Faculty Development Award

    Collapse Overview 
    Collapse Overview
    Michelle A. Albert is a Professor in Medicine at the University of California at San Francisco (UCSF) and director of the CeNter for the StUdy of AdveRsiTy and CardiovascUlaR DiseasE (NURTURE Research Center). She was the Vivian Beaumont Allen Endowed Professor/Chair and Chief of Cardiology at Howard University. Albert is a graduate of Haverford College, University of Rochester School of Medicine, Harvard School of Public Health, and completed Internal Medicine Residency and was also Chief Resident in Medicine at Columbia University. Dr. Albert then completed Cardiovascular Clinical and Research Fellowship at the Brigham and Women’s Hospital and Harvard Medical School, where she rose in the ranks to an Associate Professor in Medicine.
    Her clinical expertise involves taking care of the most critically ill advanced heart disease patients, and preventive cardiology with a focus on vulnerable populations. From a research perspective, her research has followed a non-traditional, but bold path for cardiovascular disease (CVD) research -- first characterizing the predictive capability of novel inflammatory and thrombotic biomarkers of CVD risk at the population level, to identifying how noted relationships vary by important social and demographic characteristics, and now to defining the mechanisms of differential cardiovascular disease risk across the life-course in children, older populations, women and racial/ethnic minorities exposed to adversity, i.e “the biology of adversity”.
    She was Vice-President and Board Member of the Association of Black Cardiologists (ABC), a member of the National Academy of Sciences Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease and serves as a reviewer for multiple journals including currently as Associate Editor at Atherosclerosis, Thrombosis & Vascular Biology (ATVB), a member of the Editorial Board of Circulation and as Section Editor for Current Cardiovascular Risk Reports. Dr Albert is also a member of the Association of University Cardiologists. She served/s on several national committees of the American College of Cardiology (ACC) and American Heart Association (AHA) including as a member of the Epidemiology Council, the AHA National Research Committee, Executive Committee-Clinical Cardiology Council, SACC, AHA Executive Database Steering Committee (Chair), Sarnoff Foundation Scientific Board and is a current Board Member and is President-Elect, AHA San Francisco/Bay Area Board.
    A recipient of multiple research awards, including multi-million dollar R01 funding from the NIH and funding from RWJ, Kellogg and Doris Duke Foundations, Dr. Albert enjoys mentoring trainees at all levels across the United States and was nominated for the competitive 2011-2012 Excellence in Mentoring Award at Harvard Medical School. She is a recipient of Woman’s Day Magazine’s Red Dress Award (2014), received the Haverford College Alumni Award (2015) and is the recipient of the 2016 Women in Cardiology Mentoring Award from the AHA. She is one of two recipients of the prestigious 2018 AHA Merit award for visionary research.


    Collapse ORNG Applications 
    Collapse Websites
    Collapse In The News
    Collapse Faculty Mentoring
    Collapse Global Health

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Powell-Wiley TM, Ngwa J, Kebede S, Lu D, Schulte PJ, Bhatt DL, Yancy C, Fonarow GC, Albert M. Impact of Body Mass Index on Heart Failure by Race/Ethnicity From the Get With The Guidelines-Heart Failure (GWTG-HF) Registry. JACC Heart Fail. 2018 Mar; 6(3):233-242. PMID: 29428434.
      View in: PubMed
    2. Carnethon MR, Pu J, Howard G, Albert M, Anderson CAM, Bertoni AG, Mujahid MS, Palaniappan L, Taylor HA, Willis M, Yancy CW. Cardiovascular Health in African Americans: A Scientific Statement From the American Heart Association. Circulation. 2017 Nov 21; 136(21):e393-e423. PMID: 29061565.
      View in: PubMed
    3. Albert M, Durazo EM, Slopen N, Zaslavsky AM, Buring JE, Silva T, Chasman D, Williams DR. Cumulative psychological stress and cardiovascular disease risk in middle aged and older women: Rationale, design, and baseline characteristics. Am Heart J. 2017 Oct; 192:1-12. PMID: 28938955.
      View in: PubMed
    4. Cuevas AG, Williams DR, Albert M. Psychosocial Factors and Hypertension: A Review of the Literature. Cardiol Clin. 2017 May; 35(2):223-230. PMID: 28411896.
      View in: PubMed
    5. Slopen N, Chen Y, Guida JL, Albert M, Williams DR. Positive childhood experiences and ideal cardiovascular health in midlife: Associations and mediators. Prev Med. 2017 Apr; 97:72-79. PMID: 28087467.
      View in: PubMed
    6. Hira RS, Bhatt DL, Fonarow GC, Heidenreich PA, Ju C, Virani SS, Bozkurt B, Petersen LA, Hernandez AF, Schwamm LH, Eapen ZJ, Albert M, Liang L, Matsouaka RA, Peterson ED, Jneid H. Temporal Trends in Care and Outcomes of Patients Receiving Fibrinolytic Therapy Compared to Primary Percutaneous Coronary Intervention: Insights From the Get With The Guidelines Coronary Artery Disease (GWTG-CAD) Registry. J Am Heart Assoc. 2016 Oct 06; 5(10). PMID: 27792640.
      View in: PubMed
    7. Cozier YC, Albert M, Castro-Webb N, Coogan PF, Ridker P, Kaufman HW, Palmer JR, Rosenberg L. Neighborhood Socioeconomic Status in Relation to Serum Biomarkers in the Black Women's Health Study. J Urban Health. 2016 Apr; 93(2):279-91. PMID: 27000125; PMCID: PMC4835359 [Available on 04/01/17].
    8. Slopen N, Chen Y, Priest N, Albert M, Williams DR. Emotional and instrumental support during childhood and biological dysregulation in midlife. Prev Med. 2016 Mar; 84:90-6. PMID: 26708307; PMCID: PMC4758867 [Available on 03/01/17].
    9. Slopen N, Shonkoff JP, Albert M, Yoshikawa H, Jacobs A, Stoltz R, Williams DR. Racial Disparities in Child Adversity in the U.S.: Interactions With Family Immigration History and Income. Am J Prev Med. 2016 Jan; 50(1):47-56. PMID: 26342634.
      View in: PubMed
    10. Slopen N, Non A, Williams DR, Roberts AL, Albert M. Childhood adversity, adult neighborhood context, and cumulative biological risk for chronic diseases in adulthood. Psychosom Med. 2014 Sep; 76(7):481-9. PMID: 25077427; PMCID: PMC4353633.
    11. Albert M, Ayanian JZ, Silbaugh TS, Lovett A, Resnic F, Jacobs A, Normand SL. Early results of Massachusetts healthcare reform on racial, ethnic, and socioeconomic disparities in cardiovascular care. Circulation. 2014 Jun 17; 129(24):2528-38. PMID: 24727094.
      View in: PubMed
    12. Redmond N, Richman J, Gamboa CM, Albert M, Sims M, Durant RW, Glasser SP, Safford MM. Perceived stress is associated with incident coronary heart disease and all-cause mortality in low- but not high-income participants in the Reasons for Geographic And Racial Differences in Stroke study. J Am Heart Assoc. 2013 Dec 19; 2(6):e000447. PMID: 24356528; PMCID: PMC3886761.
    13. Albert M. Not there yet: Medicare Part D and elimination of cardiovascular medication usage sociodemographic disparities after myocardial infarction. Circulation. 2014 Feb 18; 129(7):723-4. PMID: 24326989.
      View in: PubMed
    14. Slopen N, Kontos EZ, Ryff CD, Ayanian JZ, Albert M, Williams DR. Psychosocial stress and cigarette smoking persistence, cessation, and relapse over 9-10 years: a prospective study of middle-aged adults in the United States. Cancer Causes Control. 2013 Oct; 24(10):1849-63. PMID: 23860953; PMCID: PMC3776130.
    15. Plitt A, Dorbala S, Albert M, Giugliano RP. Cardiac sarcoidosis: case report, workup, and review of the literature. Cardiol Ther. 2013 Dec; 2(2):181-97. PMID: 25135396; PMCID: PMC4107425.
    16. Clark CR, Ommerborn MJ, Hickson DA, Grooms KN, Sims M, Taylor HA, Albert M. Neighborhood disadvantage, neighborhood safety and cardiometabolic risk factors in African Americans: biosocial associations in the Jackson Heart study. PLoS One. 2013; 8(5):e63254. PMID: 23691005; PMCID: PMC3653956.
    17. Mosca L, Hammond G, Mochari-Greenberger H, Towfighi A, Albert M. Fifteen-year trends in awareness of heart disease in women: results of a 2012 American Heart Association national survey. Circulation. 2013 Mar 19; 127(11):1254-63, e1-29. PMID: 23429926; PMCID: PMC3684065.
    18. Powell-Wiley TM, Ayers CR, de Lemos JA, Lakoski SG, Vega GL, Grundy S, Das SR, Banks-Richard K, Albert M. Relationship between perceptions about neighborhood environment and prevalent obesity: data from the Dallas Heart Study. Obesity (Silver Spring). 2013 Jan; 21(1):E14-21. PMID: 23404728; PMCID: PMC3602329.
    19. Slopen N, Glynn RJ, Buring JE, Lewis TT, Williams DR, Albert M. Job strain, job insecurity, and incident cardiovascular disease in the Women's Health Study: results from a 10-year prospective study. PLoS One. 2012; 7(7):e40512. PMID: 22815754; PMCID: PMC3399852.
    20. Tsenkova VK, Albert M, Georgiades A, Ryff CD. Trait anxiety and glucose metabolism in people without diabetes: vulnerabilities among black women. Diabet Med. 2012 Jun; 29(6):803-6. PMID: 22587407; PMCID: PMC3395206.
    21. Slopen N, Dutra LM, Williams DR, Mujahid MS, Lewis TT, Bennett GG, Ryff CD, Albert M. Psychosocial stressors and cigarette smoking among African American adults in midlife. Nicotine Tob Res. 2012 Oct; 14(10):1161-9. PMID: 22367977; PMCID: PMC3457711.
    22. Lee TC, Glynn RJ, Peña JM, Paynter NP, Conen D, Ridker PM, Pradhan AD, Buring JE, Albert M. Socioeconomic status and incident type 2 diabetes mellitus: data from the Women's Health Study. PLoS One. 2011; 6(12):e27670. PMID: 22194788; PMCID: PMC3237410.
    23. Albert M. Biomarkers and heart disease. J Clin Sleep Med. 2011 Oct 15; 7(5 Suppl):S9-11. PMID: 22003335; PMCID: PMC3190417.
    24. Manson JE, Bassuk SS, Lee IM, Cook NR, Albert M, Gordon D, Zaharris E, Macfadyen JG, Danielson E, Lin J, Zhang SM, Buring JE. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp Clin Trials. 2012 Jan; 33(1):159-71. PMID: 21986389; PMCID: PMC3253961.
    25. Albert M, Glynn RJ, Fonseca FA, Lorenzatti AJ, Ferdinand KC, MacFadyen JG, Ridker PM. Race, ethnicity, and the efficacy of rosuvastatin in primary prevention: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial. Am Heart J. 2011 Jul; 162(1):106-14.e2. PMID: 21742096.
      View in: PubMed
    26. Albert M, Williams DR. Invited commentary: Discrimination--an emerging target for reducing risk of cardiovascular disease? Am J Epidemiol. 2011 Jun 01; 173(11):1240-3. PMID: 21354989.
      View in: PubMed
    27. Powell TM, de Lemos JA, Banks K, Ayers CR, Rohatgi A, Khera A, McGuire DK, Berry JD, Albert M, Vega GL, Grundy SM, Das SR. Body size misperception: a novel determinant in the obesity epidemic. Arch Intern Med. 2010 Oct 11; 170(18):1695-7. PMID: 20937931; PMCID: PMC4874507.
    28. Moukarbel GV, Albert M. The ecology of stent thrombosis: a view from a sociobiological perspective. Circulation. 2010 Sep 14; 122(11):1053-5. PMID: 20805426.
      View in: PubMed
    29. Albert M. Receipt of high-quality coronary heart disease care in the United States: all about being black or white: comment on "Racial differences in admissions to high-quality hospitals for coronary heart disease". Arch Intern Med. 2010 Jul 26; 170(14):1216-7. PMID: 20660839.
      View in: PubMed
    30. Slopen N, Lewis TT, Gruenewald TL, Mujahid MS, Ryff CD, Albert M, Williams DR. Early life adversity and inflammation in African Americans and whites in the midlife in the United States survey. Psychosom Med. 2010 Sep; 72(7):694-701. PMID: 20595419; PMCID: PMC2939196.
    31. Albert M, Cozier Y, Ridker PM, Palmer JR, Glynn RJ, Rose L, Halevy N, Rosenberg L. Perceptions of race/ethnic discrimination in relation to mortality among Black women: results from the Black Women's Health Study. Arch Intern Med. 2010 May 24; 170(10):896-904. PMID: 20498418; PMCID: PMC3020569.
    32. Cook NR, Albert M. Regarding REGARDS: Does inflammation explain racial and regional differences in cardiovascular disease risk? Clin Chem. 2009 Sep; 55(9):1603-5. PMID: 19589843.
      View in: PubMed
    33. Albert M, Pare G, Morris A, Rose L, Buring J, Ridker PM, Zee RY. Candidate genetic variants in the fibrinogen, methylenetetrahydrofolate reductase, and intercellular adhesion molecule-1 genes and plasma levels of fibrinogen, homocysteine, and intercellular adhesion molecule-1 among various race/ethnic groups: data from the Women's Genome Health Study. Am Heart J. 2009 Apr; 157(4):777-83.e1. PMID: 19332210; PMCID: PMC2737822.
    34. Conen D, Glynn RJ, Ridker PM, Buring JE, Albert M. Socioeconomic status, blood pressure progression, and incident hypertension in a prospective cohort of female health professionals. Eur Heart J. 2009 Jun; 30(11):1378-84. PMID: 19297384; PMCID: PMC2721710.
    35. Albert M. Heart failure in the urban African enclave of Soweto: a case study of contemporary epidemiological transition in the developing world. Circulation. 2008 Dec 02; 118(23):2323-5. PMID: 19047590.
      View in: PubMed
    36. Albert M, Ravenell J, Glynn RJ, Khera A, Halevy N, de Lemos JA. Cardiovascular risk indicators and perceived race/ethnic discrimination in the Dallas Heart Study. Am Heart J. 2008 Dec; 156(6):1103-9. PMID: 19033005.
      View in: PubMed
    37. Albert M. Race/ethnicity and inflammation: is there a link to periodontal disease? J Periodontol. 2008 Jul; 79(7):1121-3. PMID: 18597591.
      View in: PubMed
    38. Albert M. Inflammatory biomarkers, race/ethnicity and cardiovascular disease. Nutr Rev. 2007 Dec; 65(12 Pt 2):S234-8. PMID: 18240555.
      View in: PubMed
    39. Albert M, Glynn RJ, Buring JE, Ridker PM. Differential effect of soluble intercellular adhesion molecule-1 on the progression of atherosclerosis as compared to arterial thrombosis: a prospective analysis of the Women's Health Study. Atherosclerosis. 2008 Mar; 197(1):297-302. PMID: 17640650; PMCID: PMC2947154.
    40. Albert M, Glynn RJ, Buring JE, Ridker PM. Relation between soluble intercellular adhesion molecule-1, homocysteine, and fibrinogen levels and race/ethnicity in women without cardiovascular disease. Am J Cardiol. 2007 May 01; 99(9):1246-51. PMID: 17478152; PMCID: PMC1939813.
    41. Albert M, Glynn RJ, Buring J, Ridker PM. Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events. Circulation. 2006 Dec 12; 114(24):2619-26. PMID: 17116764.
      View in: PubMed
    42. Albert M, Ridker PM. C-reactive protein as a risk predictor: do race/ethnicity and gender make a difference? Circulation. 2006 Aug 01; 114(5):e67-74. PMID: 16880331.
      View in: PubMed
    43. Albert M, Glynn RJ, Wolfert RL, Ridker PM. The effect of statin therapy on lipoprotein associated phospholipase A2 levels. Atherosclerosis. 2005 Sep; 182(1):193-8. PMID: 15982658.
      View in: PubMed
    44. Unic D, Mihaljevic T, Leacche M, Gasparovic H, Albert M, Byrne JG. Surgical treatment of a large left-main coronary artery aneurysm. Thorac Cardiovasc Surg. 2004 Aug; 52(4):230-1. PMID: 15293160.
      View in: PubMed
    45. Albert M, Torres J, Glynn RJ, Ridker PM. Perspective on selected issues in cardiovascular disease research with a focus on black Americans. Circulation. 2004 Jul 13; 110(2):e7-12. PMID: 15249517.
      View in: PubMed
    46. Albert M, Glynn RJ, Buring J, Ridker PM. C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study). Am J Cardiol. 2004 May 15; 93(10):1238-42. PMID: 15135696.
      View in: PubMed
    47. Albert M, Glynn RJ, Ridker PM. Effect of physical activity on serum C-reactive protein. Am J Cardiol. 2004 Jan 15; 93(2):221-5. PMID: 14715354.
      View in: PubMed
    48. Albert M, Ridker PM. Inflammatory biomarkers in African Americans: a potential link to accelerated atherosclerosis. Rev Cardiovasc Med. 2004; 5 Suppl 3:S22-7. PMID: 15303082.
      View in: PubMed
    49. Blake GJ, Albert M, Rifai N, Ridker PM. Effect of pravastatin on LDL particle concentration as determined by NMR spectroscopy: a substudy of a randomized placebo controlled trial. Eur Heart J. 2003 Oct; 24(20):1843-7. PMID: 14563343.
      View in: PubMed
    50. Albert M, Glynn RJ, Ridker PM. Plasma concentration of C-reactive protein and the calculated Framingham Coronary Heart Disease Risk Score. Circulation. 2003 Jul 15; 108(2):161-5. PMID: 12835213.
      View in: PubMed
    51. Albert M, Glynn RJ, Ridker PM. Alcohol consumption and plasma concentration of C-reactive protein. Circulation. 2003 Jan 28; 107(3):443-7. PMID: 12551869.
      View in: PubMed
    52. Albert M, Danielson E, Rifai N, Ridker PM. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA. 2001 Jul 04; 286(1):64-70. PMID: 11434828.
      View in: PubMed
    53. Albert M, Staggers J, Chew P, Ridker PM. The pravastatin inflammation CRP evaluation (PRINCE): rationale and design. Am Heart J. 2001 Jun; 141(6):893-8. PMID: 11376301.
      View in: PubMed
    54. Albert M, Rifai N, Ridker PM. Plasma levels of cystatin-C and mannose binding protein are not associated with risk of developing systemic atherosclerosis. Vasc Med. 2001; 6(3):145-9. PMID: 11789968.
      View in: PubMed
    55. Albert M. The role of C-reactive protein in cardiovascular disease risk. Curr Cardiol Rep. 2000 Jul; 2(4):274-9. PMID: 10953259.
      View in: PubMed
    56. Albert M, Ridker PM. The role of C-reactive protein in cardiovascular disease risk. Curr Cardiol Rep. 1999 Jul; 1(2):99-104. PMID: 10980827.
      View in: PubMed
    Michelle A's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP